Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Dale L Barnard

Showing results (31-40 of 60) with videos related to

Pageof 6
Sort By:
Antiviral Chemistry & Chemotherapy|July 14, 2007
Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in miceDale L Barnard, Min-Hui Wong, Kevin Bailey, et al.
Antiviral Chemistry & Chemotherapy|December 21, 2006
Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c miceDale L Barnard, Craig W Day, Kevin Bailey, et al.
Plos One|February 1, 2012
Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A virusesJack T Nguyen, Donald F Smee, Dale L Barnard, et al.
Virology|October 27, 2009
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivoCraig W Day, Ralph Baric, Sui Xiong Cai, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2006
Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in miceRobert W Sidwell, Dale L Barnard, Craig W Day, et al.
Chemotherapy|June 19, 2008
Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virusG Mani Subramanian, Paul A Moore, Brian B Gowen, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2007
Neutralizing viruses in suspensions by copper oxide-based filtersGadi Borkow, Robert W Sidwell, Donald F Smee, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2010
(-)-Carbodine: enantiomeric synthesis and in vitro antiviral activity against various strains of influenza virus including H5N1 (avian influenza) and novel 2009 H1N1 (swine flu)Jagadeeshwar R Rao, Ashok K Jha, Ravindra K Rawal, et al.
Antiviral Research|May 12, 2009
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infectionsYousuke Furuta, Kazumi Takahashi, Kimiyasu Shiraki, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
in vitro inhibition of the measles virus by novel ring-expanded ('fat') nucleoside analogues containing the imidazo[4,5-e]diazepine ring systemNing Zhang, Huan-Ming Chen, Ramesh Sood, et al.
Pageof 6

Showing results (31-40 of 60) with videos related to

Sort By:
Pageof 6
Antiviral Chemistry & Chemotherapy|July 14, 2007
Effect of oral gavage treatment with ZnAL42 and other metallo-ion formulations on influenza A H5N1 and H1N1 virus infections in miceDale L Barnard, Min-Hui Wong, Kevin Bailey, et al.
Antiviral Chemistry & Chemotherapy|December 21, 2006
Evaluation of immunomodulators, interferons and known in vitro SARS-coV inhibitors for inhibition of SARS-coV replication in BALB/c miceDale L Barnard, Craig W Day, Kevin Bailey, et al.
Plos One|February 1, 2012
Efficacy of combined therapy with amantadine, oseltamivir, and ribavirin in vivo against susceptible and amantadine-resistant influenza A virusesJack T Nguyen, Donald F Smee, Dale L Barnard, et al.
Virology|October 27, 2009
A new mouse-adapted strain of SARS-CoV as a lethal model for evaluating antiviral agents in vitro and in vivoCraig W Day, Ralph Baric, Sui Xiong Cai, et al.
Antimicrobial Agents and Chemotherapy|December 30, 2006
Efficacy of orally administered T-705 on lethal avian influenza A (H5N1) virus infections in miceRobert W Sidwell, Dale L Barnard, Craig W Day, et al.
Chemotherapy|June 19, 2008
Potent in vitro activity of the albumin fusion type 1 interferons (albumin-interferon-alpha and albumin-interferon-beta) against RNA viral agents of bioterrorism and the severe acute respiratory syndrome (SARS) virusG Mani Subramanian, Paul A Moore, Brian B Gowen, et al.
Antimicrobial Agents and Chemotherapy|May 2, 2007
Neutralizing viruses in suspensions by copper oxide-based filtersGadi Borkow, Robert W Sidwell, Donald F Smee, et al.
Bioorganic & Medicinal Chemistry Letters|March 17, 2010
(-)-Carbodine: enantiomeric synthesis and in vitro antiviral activity against various strains of influenza virus including H5N1 (avian influenza) and novel 2009 H1N1 (swine flu)Jagadeeshwar R Rao, Ashok K Jha, Ravindra K Rawal, et al.
Antiviral Research|May 12, 2009
T-705 (favipiravir) and related compounds: Novel broad-spectrum inhibitors of RNA viral infectionsYousuke Furuta, Kazumi Takahashi, Kimiyasu Shiraki, et al.
Bioorganic & Medicinal Chemistry Letters|November 7, 2002
in vitro inhibition of the measles virus by novel ring-expanded ('fat') nucleoside analogues containing the imidazo[4,5-e]diazepine ring systemNing Zhang, Huan-Ming Chen, Ramesh Sood, et al.
Pageof 6